Diabetes Mellitus Type 2 Perspective

 
 
  • Guideline vs Physician: Which Do You Trust?   Guidelines were meant to make treatment decisions easier and more evidence-based, but it hasn't quite worked out that way, says Dr Lundberg.
  • 5 Types of Diabetes: Can New Analysis Make Care Easier?   A new classification system may enable more personalized management approaches and improve outcomes.
  • Congress to Help Medicare Patients Obtain Diabetes Supplies A cost-cutting strategy adopted several years ago, called the competitive bidding program, caused access issues for many patients with diabetes; Congress is now trying to remedy the problem.
  • ADA 2018 Read clinically focused news coverage of key developments from ADA 2018.
  • Specialists vs Primary Care: Whose Guidelines Matter? It may not exactly be a schism, but primary and specialty care are increasingly at odds over which field of practice's guidelines are best for patients.
  • A Quick Planner for ADA ADA meeting veteran Gregory Nichols offers a guide to the upcoming ADA 78th Scientific Sessions and which sessions have sparked his interest.
  • Detecting Diabetic Retinopathy: Can AI Provide a Better Way? The inevitable advance of artificial intelligence has begun with the first approved system that can detect diabetic retinopathy on its own. How might it affect clinicians who screen for eye disease?
  • Simple Tool Predicts 2-Year Diabetes Risk An operational question about allocating diabetes resources results in a simple algorithm that identifies the people at highest risk for developing diabetes.
  • Patients With Diabetes: Let Them Eat Eggs   Dr Charles Vega reviews a study looking at the effect of including eggs in the diets of people with diabetes.
  • Formulary Snafus In an era of competing formularies and demands for preauthorization, taking a prescription to the pharmacy is often the beginning of a frustrating misadventure for patients and physicians alike.
  • Choosing Insulin: A New Wrinkle   Dr Arefa Cassoobhoy reviews a whitepaper on the affordability of insulin and how this affects treatment adherence.
  • We Can't Just Give Up on Obesity A pediatric endocrinologist describes the harsh realities of practicing in the South today and calls on the medical profession to redress 'sins of the past.'
  • ACP Glycemic Target Guidance: An Author Makes the Case   Dr Jay H. Shubrook interviews Dr Timothy J. Wilt on ACP's updated guidance statement on pharmacologic treatment of nonpregnant patients with type 2 diabetes mellitus.
  • Detect Diabetes Sooner With Expanded Criteria   Dr Arefa Cassoobhoy highlights a study showing that the current screening criteria are missing many patients with prediabetes or diabetes.
  • Extreme Diets: Fads and Facts Radical diets have exploded in popularity since the 19th century. We dig into notable examples -- from Fletcherism to liquid diets to Beverly Hills -- reviewing their history, claims, and impact.
  • NAFLD Is a Growing Problem Recent guidance from the American Association for the Study of Liver Diseases for the evaluation and management of patients with nonalcoholic fatty liver disease is profiled.
  • SGLT2 Inhibitors: Unreal Primary Prevention? These diabetes drugs offer cardiovascular benefits, but only in diabetes patients who already have CV disease, the author argues.
  • AACE 2018 Read clinically focused news coverage of key developments from AACE 2018.
  • Should We View Obesity as Normal and Okay?   Many people say that obesity is normal. An expert says we shouldn't shame people because they're fat, but we shouldn't concede that being fat is normal either, because it is unhealthy.
  • Type 2 DM: The Case for the ADA Standards in Primary Care   A member of the American Diabetes Association's Primary Care Advisory Group describes the evidence-based process underpinning the annual document guiding care for patients with type 2 diabetes.